Loading company…
MyX Therapeutics Inc., based in Montreal, Quebec, develops a mucosal delivery platform for novel drug products.
Founded in 2018 and based in Montreal, Quebec, MyX Therapeutics provides a mucosal delivery platform technology. The technology is used to develop products for ophthalmic, sublingual, intranasal and vaginal drug delivery.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in